OnKure Therapeutics (OKUR) Interest Income - Total (2024 - 2026)
OnKure Therapeutics' (OKUR) quarterly Interest Income - Total came in at $458000.0 in Q1 2026, down 57.4% YoY from $1.1 million in Q1 2025, and down 27.07% on a QoQ basis from $628000.0 in Q4 2025.
OnKure Therapeutics (OKUR) Interest Income - Total (2024 - 2026) Analysis & Trends
OnKure Therapeutics (OKUR) has 3 years of Interest Income - Total data on file, last reported at $458000.0 in Q1 2026.
- Quarterly Interest Income - Total fell 57.4% year-over-year to $458000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 1.11% YoY) and the FY2025 annual result came in at $3.4 million, up 70.94% from the prior year.
- Interest Income - Total fell to $458000.0 in Q1 2026, from $628000.0 in the prior quarter.
- In the past five years, Interest Income - Total ranged from a high of $1.3 million in Q4 2024 to a low of $174000.0 in Q3 2024.
- A 3-year average of $656888.9 and a median of $628000.0 in 2025 frame the typical range for Interest Income - Total.
- Annual changes were most pronounced in 2025 — Interest Income - Total jumped 362.07% — and 2026, when it slumped 57.4%.
- Tracing OKUR's Interest Income - Total over 3 years: stood at $1.3 million in 2024, then sank by 52.21% to $628000.0 in 2025, then dropped by 27.07% to $458000.0 in 2026.
- The last three Interest Income - Total figures came in at $458000.0 (Q1 2026), $628000.0 (Q4 2025), and $804000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Total (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | OnKure Therapeutics | 195.74 Mn | 19.35 Mn | - | 1.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.55 Mn |
| Jun 30, 2026 | 1.55 Mn |
| Mar 31, 2026 | 458,000.00 |
| Mar 31, 2026 | 458,000.00 |
| Dec 31, 2025 | 628,000.00 |
| Dec 31, 2025 | 628,000.00 |
| Sep 30, 2025 | 804,000.00 |
| Sep 30, 2025 | 804,000.00 |
| Jun 30, 2025 | 934,000.00 |
| Jun 30, 2025 | 934,000.00 |
| Mar 31, 2025 | 1.08 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 174,000.00 |
| Sep 30, 2024 | 174,000.00 |
| Jun 30, 2024 | 230,000.00 |
| Jun 30, 2024 | 230,000.00 |
| Mar 31, 2024 | 295,000.00 |
| Mar 31, 2024 | 295,000.00 |